Development and validation of a coding framework to identify severe acute toxicity from systemic anti-cancer therapy using hospital administrative data-Reference-Cited by-同舟云学术

Development and validation of a coding framework to identify severe acute toxicity from systemic anti-cancer therapy using hospital administrative data

Published:2022-04 Issue: Volume:77 Page:102096
ISSN:1877-7821
Container-title:Cancer Epidemiology
language:en
Short-container-title:Cancer Epidemiology

Author:

Boyle Jemma M.,Cowling Thomas E.,Kuryba Angela,Fearnhead Nicola S.,van der Meulen Jan,Braun Michael S.,Walker Kate,Aggarwal Ajay

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Epidemiology

Reference52 articles.

1. Can chemotherapy-related acute care visits be accurately identified in administrative data?;Krzyzanowska;J. Oncol. Pract.,2018

2. Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies;McKee;BMJ,1999

3. Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies;Sørensen;Hepatology,2006

4. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer;Hassett;J. Nat. Cancer Inst.,2006

5. The impact of socioeconomic status and race on trial participation for older women with breast cancer;Gross;Cancer,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospital Factors Influencing the Mobility of Patients for Systemic Therapies in Breast and Bowel Cancer in the Metastatic Setting: A National Population-based Evaluation;Clinical Oncology;2024-10

2. The future of cancer care in the UK—time for a radical and sustainable National Cancer Plan;The Lancet Oncology;2024-01

4. The Association Between Survival and Receipt of Post-mastectomy Radiotherapy According to Age at Diagnosis Among Women With Early Invasive Breast Cancer: A Population-Based Cohort Study;Clinical Oncology;2023-04

5. Real World Data – Does it Cut the Mustard or Should We Take it With a Pinch of Salt?;Clinical Oncology;2023-01